New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.

News & Blog

Catch the latest

Recent Announcements & Press

March 7, 2022

ViVE 2022: Making Value-Based Care a Widespread Reality in Healthcare – HealthTech Magazine

March 2, 2022

Octave Bioscience Building Evidence Base for Multiple Sclerosis Test to Support Clinical Launch – 360Dx

February 25, 2022

Octave Presents Clinical Validation Results of its Multivariate Blood-based Multiple Sclerosis Disease Activity Biomarker Test at ACTRIMS Forum 2022

Octave Note

Media Library